Aktive Positionen von Frank M. Longo
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
PharmatrophiX, Inc.
 PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Vorsitzender | 01.01.2005 | - |
| Gründer | 01.01.2005 | - | |
| Stanford University | Corporate Officer/Principal | 01.01.2006 | - |
Karriereverlauf von Frank M. Longo
Ausbildung von Frank M. Longo
| University of California San Diego | Doctorate Degree |
| Harvard T.H. Chan School of Public Health | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Doctorate Degree | 2 |
| Chairman | 1 |
| Founder | 1 |
Sektoral
| Consumer Services | 4 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
PharmatrophiX, Inc.
PharmatrophiX, Inc. BiotechnologyHealth Technology PharmatrophiX, Inc. develops a drug technology targeting neurodegenerative disorders. The firm is currently focusing on Alzheimer''s disease treatment. It has two development programs, p75 receptor program and Trk ligand program which targets a spectrum of neurological and non-neurological disorders. The company was founded by Frank M. Longo in 2005 and is headquartered in Raleigh, NC. | Health Technology |
- Börse
- Insiders
- Frank M. Longo
- Erfahrung
